Taylor Thompson, M.D.


Physician Investigator (Cl)
Pulmonary, Mass General Research Institute
Professor of Medicine
Harvard Medical School
Physician
Pulmonary, Massachusetts General Hospital
MD UC Davis School of Medicine 1978
acute lung injury; adrenergic beta-2 receptor agonists; albuterol; critical care; intensive care; intensive care units; lung injury; pulmonary alveoli; respiration, artificial; respiratory distress syndrome, adult; sepsis; tidal volume Dr. Thompson is the Medical Director of the NHLBI-funded Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Coordinating Center where he coordinates randomized controlled trials for critically ill patients. In collaboration with Drs' Christiani and Bajwa at MGH, Dr. Thompson is exploring the molecular epidemiology of ARDS susceptibility and ARDS and sepsis clinical outcomes. Dr Thompson is working with Dr. Michael Matthay at UCSF on the design and implementation of a Phase II trial of mesenchymal stem cells for the treatment of ALI and with Augustine Choi at the Brigham and Women's Hospital on the design and implementation of a clinical trial of inhaled carbon monoxide as a potential therapeutic agent for ARDS.
Publications Clinical Profile
tthompson1@mgh.harvard.edu
6176432411

Bulfinch Building
66 Blossom Street
Boston, MA 02114